Clinical Research Directory
Browse clinical research sites, groups, and studies.
Pilot Exploration of Platelet Characterization of Platelet Rich Plasma Created by Two Different Systems
Sponsor: University of California, San Francisco
Summary
The investigators would like to study the differences in the quality of Platelet Rich Plasma (PRP) between two different machines in those with knee osteoarthritis. Knee osteoarthritis means your cartilage has been worn down, and it affects your knee joint. Both machines, the APEX Biologix XCELL PRP System and the Emcyte PurePRP Supraphysiologic Concentrating System, are FDA approved, commercially available, and makes PRP. The investigators will check if the platelets in the PRP have different amounts or work differently. The investigators will also assess participants symptoms after the injection and compare the two different preparation systems.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2026-03
Completion Date
2028-09
Last Updated
2026-03-24
Healthy Volunteers
No
Interventions
Platelet Rich Plasma
The Platelet Rich Plasma (PRP) participants will receive in this study will be made by Emcyte PurePRP Supraphysiologic Concentrating System or the APEX Biologix XCELL PRP System.
Emcyte PurePRP Supraphysiologic Concentrating System
Platelet Rich Plasma (PRP) will be made by the Emcyte PurePRP Supraphysiologic Concentrating System.
APEX Biologix XCELL PRP System
Platelet Rich Plasma (PRP) will be made by APEX Biologix XCELL PRP System.
Locations (1)
University of California San Francisco
San Francisco, California, United States